The meetings, held by the government’s initiative to speed COVID-19 vaccine and drug development, typically focus on vaccine distribution, therapeutics, manufacturing and supply issues, according to Politico.
Politico previously reported that the Biden transition team was denied access to the meetings.
The senior administration official told Politico that the Biden team had been receiving regular briefings on the meetings, but had not attended any.
Read the full article here.
More articles on pharmacy:
Gilead testing remdesivir against new COVID-19 variants
Fresenius Kabi recalls NSAID due to presence of particulate matter
CVS Health names new chief people officer
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.